National Academy of Medicine

A CEO Checklist for High-Value Health Care

Health care in the United States is at a critical point. Excessive costs are no longer tenable and mediocre outcomes are no longer tolerable.
Read More

Bringing Knowledge Home

In the next 10 years, data and the ability to analyze them will do for doctors’ minds what X-ray and medical imaging have done for their vision. How? By turning
Read More

Care Transformation at Emory Hospital

The Institute of Medicine’s (IOM’s) release of the reports To Err is Human and Crossing the Quality Chasm in 1999 and 2001, respectively, were mar
Read More

Canadian Strategy on Patient-Oriented Research

In Canada, as elsewhere, the translation of health research outcomes to development of products and services for health care and final im
Read More

Novel Ways to Get Good Trial Data: The UK Experience

Traditional randomised clinical trials are very expensive and time-consuming and often have poor external validity (Ware and Hamel,
Read More

Health Research as a Public Good

The arrangements for the regulation and governance of health research in the United Kingdom (UK) have evolved, piecemeal, over the past 30 years, and m
Read More

Developing a Clinical Trials Infrastructure in the United States

Clinical trials in the United States have a rich history of involving academic, industry, and government institutions (
Read More

2012-Achieving Data Liquidity in the Cancer Community: Proposal for Coalition of All Stakeholders

Rapid, seamless data exchange in cancer throughout the continuum from research to clinical c
Read More

Transforming the Economics of Clinical Trials

Clinical trials are a means of gathering information about medical products or services. In medicine, however, they are also the fundament
Read More

2012 – Trying to Practice What I Preached: Helping My Parents at the End of Their Lives

Once again, the challenge of how to constrain rising health care expenditures has caught the public inter
Read More